| Measles is an acute highly contagious disease characterised by fever,
cough, coryza, conjunctivitis, an erythematous maculopapular rash, and a
pathognomonic enanthem (Koplik spots). Ten per cent of cases suffer such
complications as otitis media and bronchopneumonia, and encephalitis occurs
in one in 1000 cases. Complications occur more frequently with increasing
age. Three out of every 1000 cases reported in the United States since 1989
died (1).
Epidemiological surveillance in Belgium
Measles was very common in Belgium before 1985, affecting 95% of children
before they reached the age of 15 years. In 1984 the incidence of measles,
calculated using data from a general practitioner surveillance system,
was 823/100 000 inhabitants (2). With the introduction of the trivalent
measles, mumps, and rubella (MMR) vaccine for the immunisation of children
between 12 and 24 months of age coverage of measles vaccination rose from
52% in 1983 to 90% in 1990, and the incidence fell to 80/100 000 in 1990.
The incidence of measles in all age groups in Flanders - the northern
part of Belgium - rose slightly from 76/100 000 (CI 64-85) in 1991 to
87/100 000 (CI 75-101) in 1995 (2). The age specific incidence of measles
in children aged 15 to 19 years in Flanders fell from 113/100 000 in 1983
to 66/100 000 in 1986 but rose to 125/100 000 in 1992. No mass campaign
has been conducted to vaccinate school age children as was undertaken
in the United Kingdom (3,4) but in 1995 the government recommended a second
dose of the trivalent vaccine at the age of 11 years.
The outbreak
Increasing numbers of cases of measles were reported around Herentals
(a city of 30 000 inhabitants, in the north of the province of Antwerp)
by general practitioners and a university laboratory in March 1996. We
conducted an investigation to describe the outbreak in detail and to evaluate
the field efficacy of measles vaccine.
Methods
There is no statutory duty to notify cases of measles in Flanders and
although the general practitioner survey system can estimate regional
incidence it cannot supply valid local rates. We therefore looked actively
for cases to measure the impact of the outbreak. Questionnaires were sent
to 214 doctors (general practitioners and paediatricians), six local laboratories,
and the area's seven hospitals (survey A). In addition, 4092 children
who attended secondary school in Herentals were interviewed (survey B).
Their responses were compared with those from 978 children from Heist-op-den-Berg,
a small town chosen as a control population in which to estimate the background
incidence of measles (survey C). As no central records of child immunisation
are kept in Belgium, the data obtained through our questionnaires were
validated by comparing them with information from general practitioners.
A case of measles was defined as an illness characterised by a generalised
rash lasting three or more days, a fever of over 38.3ºC, and cough or
coryza or conjunctivitis (5).
Laboratory criteria for the diagnosis were the detection of a significant
(fourfold) rise in measles antibody titre or the identification of specific
measles IgM antibody. Cases that met the clinical definition were described
as probable; confirmed cases were either laboratory confirmed or clinical
cases epidemiologically linked to a confirmed or a probable case (5).
The study was conducted during six months of 1996 and the area was geographically
limited to Herentals, Heist, and their surrounding municipalities.
Results
In survey A, 26 (12%) of the general practitioners we interviewed reported
122 confirmed cases of measles, (95) 78% of whom were more than 10 years
of age. The highest attack rates occurred in February and March (figure
1). Laboratories reported eight serologically confirmed cases. Survey
B of schoolchildren in Herentals had a response rate of 88% (3621 forms),
and suggested that 301 (8.2%) of the children had suffered from measles
during 1996. Survey C of the reference group from Heist-op-den-Berg had
a response rate of 77% (759 of 978 children), seven (1%) of whom had suffered
from measles during 1996. Integration of data from surveys A and B, after
removing duplicates by date of birth, provided 345 cases for 307 for whom
complete data were available. Thirty-eight per cent of cases had been
vaccinated. Children who had not been vaccinated were six times more likely
to develop measles than those who had been vaccinated once at the age
of 15 months. The estimated vaccine efficacy was 80.9%. (95% CI: 76.2-84.6)

Recommendations
A local programme of MMR vaccination and revaccination of the schoolchildren
and their siblings with MMR was recommended during the outbreak. MMR vaccine
was delivered free of charge.
Discussion
Clinical data must be interpreted carefully, but it is clear that an
outbreak of measles occurred in Herentals early in 1996. This outbreak
may be explained by the relatively low vaccine coverage among children
in the age groups affected. They were too old to have been included in
vaccination against measles in the second year of life, which began in
1985. In addition this cohort stood less chance of acquiring natural infection
than earlier cohorts because less measles was circulating in the population.
The relatively advanced age of these cases - most over 14 years - is the
consequence of the same fact. The outbreak described here can be seen
as an adverse consequence of a campaign to vaccinate children once
in the second year of life without providing catch up vaccination for
older children. The morbidity and mortality of measles and the high risk
of further outbreaks in the near future are arguments for holding a mass
campaign to immunise all children of school age. It will be held in autumn
1996 to avoid the next wave of cases: cases of measles occur mainly in
the late winter and early spring.
|
| References
1. American Academy of Pediatrics. 1994 red book: report of the Committee
on Infectious Diseases. Elk Grove Village: American Academy of Pediatrics,
1994.
2. Van der Veken J, Van Casteren V. Surveillance van mazelen en bof door
de Belgische huisartsenpeilpraktijken 1982-1993. Brussel: IHE, 1994.
3. Ramsay M, Gay N, Miller E, Rush M, White J, Morgan-Capner P, Brown
D. The epidemiology of measles in England and Wales: rationale for 1994
national vaccination campaign. Commun Dis Rep CDR Rev 1994; 12:141-6.
4. Miller E. The new measles campaign. BMJ 1994; 309:1102-3.
5. CDC. Case definitions for public health surveillance. MMWR Recommendations
and Reports 1990; 39(13) :23.
|